Ipragliflozin (Suglat)

ipragliflozin · Astellas Pharma Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Ipragliflozin (Suglat), covering 2024-11-12 to 2024-11-12. Get the full timeline:

Most recent: Clinical Trial Update: Study of Ipragliflozin in Patients With Type 2 Diabetes Mellitus Receiving Insulin Therapy [Phase 4]